These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3136893)

  • 21. Endotoxaemia in acute hepatic failure.
    Liehr H; Grün M; Brunswig D
    Acta Hepatogastroenterol (Stuttg); 1976; 23(4):235-40. PubMed ID: 823763
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased sinusoidal efflux of reduced and oxidized glutathione in rats with endotoxin/D-galactosamine hepatitis.
    Irita K; Okabe H; Koga A; Kurosawa K; Tagawa K; Yamakawa M; Yoshitake J; Takahashi S
    Circ Shock; 1994 Mar; 42(3):115-20. PubMed ID: 8025975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of gut-derived endotoxemia with lactulose. An experimental study].
    Hou RX
    Zhonghua Wai Ke Za Zhi; 1991 Apr; 29(4):248-50, 272. PubMed ID: 1874117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of disulfiram on function of the liver of rats with galactosamine-induced hepatitis.
    Mach T
    Pol J Pharmacol Pharm; 1986; 38(3):235-41. PubMed ID: 3095801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of azathioprine and phenobarbital on acute liver damage produced by galactosamine.
    Perings E; Brunner G; Vido I; Söling HD; Creutzfeldt W
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):130-4. PubMed ID: 4148023
    [No Abstract]   [Full Text] [Related]  

  • 28. [Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model].
    Leinweber B; Mahrt R
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():300-3. PubMed ID: 1029192
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacies of whole blood and plasma cross circulation on galactosamine induced hepatic failure rats.
    Okabe K; Ouchi K; Koyama K; Sato T
    Trans Am Soc Artif Intern Organs; 1984; 30():395-8. PubMed ID: 6533913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental study on injurious effect of burn combined with endotoxemia on the liver and its significance].
    Liu YS; Yan LS
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1994 Mar; 10(2):142-5. PubMed ID: 7922817
    [No Abstract]   [Full Text] [Related]  

  • 31. Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury.
    Shibayama Y
    J Pathol; 1987 Apr; 151(4):315-21. PubMed ID: 3585589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of galactosamine hepatitis using administration of D-galactose: significance of temporally limited UDP-galactose deficit for the induction of galactosamine hepatitis].
    Bauer C; Reutter W; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1502. PubMed ID: 4649767
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of depletion of glucocorticoid receptor in the production of multiple organ failure during endotoxemia].
    Fan J
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1992 Mar; 8(1):28-31, 85-6. PubMed ID: 1596788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of magnesium lithospermate B on D-galactosamine induced rat liver injury].
    Liu P; Mizoguchi Y; Morisawa S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Jun; 13(6):352-3, 326. PubMed ID: 8257841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the effect of liver cytosol on experimental acute hepatic failure in the rat].
    Ha TZ
    Zhonghua Yi Xue Za Zhi; 1989 May; 69(5):267-70, 18. PubMed ID: 2804738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of putrescine on experimental acute hepatic injury in rats].
    Wu XM; Zhang BG; Zhou Q; Li BR
    Yao Xue Xue Bao; 1988 Mar; 23(3):161-7. PubMed ID: 3421104
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of essential phospholipids on the galactosamine hepatitis in rats].
    Petzold H; Titlbach O
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983
    [No Abstract]   [Full Text] [Related]  

  • 38. [Specific hepatotoxic effect of D-galactosamine].
    Andreicut S; Kerekes M
    Morphol Embryol (Bucur); 1977; 23(3):221-5. PubMed ID: 142915
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of single or consecutive administration of T-2588 on hepatic-injured male rats].
    Shimotori T; Shibata T; Nakagawa S; Sato S; Nagai A; Yoneda T
    Jpn J Antibiot; 1986 Sep; 39(9):2307-23. PubMed ID: 3795480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Endotoxin-inactivating activity in normal and D-galactosamine induced liver failure rats].
    Taki S; Nakao A
    Nihon Geka Gakkai Zasshi; 1993 Dec; 94(12):1256-62. PubMed ID: 8272064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.